SCHEMBL6176969

SCHEMBL6176969

O=C(O)C=C(Cc1ccc(OCc2ccccc2)cc1)c1nccs1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 5/20 0.47
FFAR1 O14842 2/20 0.47
FFAR4 Q5NUL3 1/20 0.44
NR4A1 P22736 1/20 0.44
NR4A2 P43354 1/20 0.44
NR4A3 Q92570 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
KDM4E B2RXH2 1/20 0.43
TP53 P04637 1/20 0.43
MAPT P10636 1/20 0.43
LTB4R Q15722 1/20 0.43
LTB4R2 Q9NPC1 1/20 0.43
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43
PLA2G4A P47712 1/20 0.43
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
MAOB P27338 1/20 0.42
PARP10 Q53GL7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6176965 1.00 ALOX5 (0.47) ALOX5FFAR1FFAR4NR4A1NR4A2
SCHEMBL6177200 0.84 PLA2G4A (0.53) ALOX5FFAR1FFAR4NR4A1NR4A2
SCHEMBL6178946 0.81 ALOX5 (0.47) ALOX5FFAR1FFAR4NR4A1NR4A2
SCHEMBL6178942 0.81 ALOX5 (0.47) ALOX5FFAR1FFAR4NR4A1NR4A2
SCHEMBL6490658 0.81 ALOX5 (0.49) ALOX5FFAR1FFAR4NR4A1NR4A2
SCHEMBL6502665 0.81 ALOX5 (0.49) ALOX5FFAR1FFAR4NR4A1NR4A2
SCHEMBL6177229 0.80 ALOX5 (0.50) ALOX5FFAR1FFAR4NR4A1NR4A2
SCHEMBL6177225 0.80 ALOX5 (0.50) ALOX5FFAR1FFAR4NR4A1NR4A2
SCHEMBL6178043 0.79 NPC1 (0.54) ALOX5MEN1KMT2ATP53MAPT
SCHEMBL6178029 0.79 NPC1 (0.54) ALOX5MEN1KMT2ATP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1061921-A4 VITRONECTIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2005-03-30 EP disclosed
US-20020147334-A1 Vitronectin Receptor Antagonists SMITHKLINE BEECHAM CORPORATION 2002-10-10 US disclosed
EP-1061921-A1 VITRONECTIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2000-12-27 EP disclosed
WO-1999045927-A1 VITRONECTIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1999-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020147334-A1 Vitronectin Receptor Antagonists ADGRF1, FN1, CALCR ALOX5 1898/4885FFAR1 151/4885FFAR4 419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.